While rexinoids have demonstrated insulin sensitizing, glucose lowering and anti-obesity effects in animal models of disease they have been associated with undesirable effects as hypertriglyceridemia and suppression of the thyroid hormone axis both in animals and in humans [29]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.